Real World Barriers to Early Treatment in Smoldering Multiple Myeloma

In this segment, Dr. Sagar Lonial asks the panel to discuss real world challenges that may limit the use of early treatment strategies in patients with high risk smoldering multiple myeloma. Dr. Saad Usmani explains that logistical considerations, including access to specialized care, infusion capacity, and the need for frequent monitoring, can affect how easily early treatment approaches are implemented in routine practice. He notes that these factors may vary between academic centers and community settings. The discussion also addresses the influence of insurance coverage and reimbursement policies when considering treatment for patients who remain asymptomatic. Dr. Vincent Rajkumar highlights that payer requirements and regional practice differences can shape how clinicians discuss treatment options with patients. Together, the panel emphasizes that while clinical trial data are informing new treatment strategies in smoldering multiple myeloma, practical considerations related to access, coverage, and healthcare infrastructure remain important factors in real world decision making.